{
     "PMID": "6330621",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19840813",
     "LR": "20171118",
     "IS": "0304-3940 (Print) 0304-3940 (Linking)",
     "VI": "46",
     "IP": "2",
     "DP": "1984 May 4",
     "TI": "Autoradiographic mapping of spirodecanone binding-sites in the hippocampal region of the rat. Evidence for a localization on intrinsic neurons.",
     "PG": "179-84",
     "AB": "The method of in vitro receptor autoradiography was used to map the distribution of spirodecanone binding-sites in the rat hippocampal region. Incubations of horizontal sections through the hippocampus with [3H]spiperone (1 nM) resulted in dense labeling restricted to the pyramid cell layer in CA1, the parasubiculum and layers I and II of the entorhinal area (EA), while the other hippocampal subfields contained moderate to low binding. ADTN, serotonin, ketanserin and mianserin (1-100 microM) all failed to displace the [3H]spiperone in the layers of densest binding, while displacement of the [3H]spiperone binding occurred with high concentrations of spiperone (1 microM) and haloperidol (100 microM). Intra-entorhinal injections of the neurotoxin ibotenic acid prevented [3H]spiperone binding to layers I and II of the EA, while transections of septal and commissural afferents or the degeneration of serotonin and noradrenaline terminals appeared not to reduce the [3H]spiperone binding in any part of the hippocampal region. These findings suggest that spirodecanone binding-sites are located on intrinsic neurons in restricted laminae of the hippocampal region.",
     "FAU": [
          "Kohler, C"
     ],
     "AU": [
          "Kohler C"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article"
     ],
     "PL": "Ireland",
     "TA": "Neurosci Lett",
     "JT": "Neuroscience letters",
     "JID": "7600130",
     "RN": [
          "0 (Butyrophenones)",
          "0 (Piperidines)",
          "0 (Receptors, Cell Surface)",
          "0 (Receptors, Dopamine)",
          "0 (Tetrahydronaphthalenes)",
          "0 (spirodecanone receptor)",
          "250PJI13LM (Mianserin)",
          "333DO1RDJY (Serotonin)",
          "4X6E73CJ0Q (Spiperone)",
          "53463-78-8 (ADTN)",
          "97F9DE4CT4 (Ketanserin)",
          "J6292F8L3D (Haloperidol)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Autoradiography",
          "Binding, Competitive",
          "Brain Mapping",
          "Butyrophenones/*metabolism",
          "Haloperidol/metabolism",
          "Hippocampus/*metabolism",
          "Ketanserin",
          "Male",
          "Mianserin/metabolism",
          "Piperidines/metabolism",
          "Rats",
          "Rats, Inbred Strains",
          "Receptors, Cell Surface/*metabolism",
          "*Receptors, Dopamine",
          "Serotonin/metabolism",
          "Spiperone/*metabolism",
          "Tetrahydronaphthalenes/metabolism"
     ],
     "EDAT": "1984/05/04 00:00",
     "MHDA": "1984/05/04 00:01",
     "CRDT": [
          "1984/05/04 00:00"
     ],
     "PHST": [
          "1984/05/04 00:00 [pubmed]",
          "1984/05/04 00:01 [medline]",
          "1984/05/04 00:00 [entrez]"
     ],
     "AID": [
          "0304-3940(84)90438-5 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neurosci Lett. 1984 May 4;46(2):179-84.",
     "term": "hippocampus"
}